In a groundbreaking move, Procter & Gamble (P&G) has added a powerhouse to its board of directors. Ashley McEvoy, the former Executive Vice President and worldwide chairman of MedTech at Johnson & Johnson, officially joined the P&G board on December 12, 2023, bringing with her an impressive legacy of nearly three decades of transformative leadership.
McEvoy’s illustrious career at Johnson & Johnson speaks volumes, particularly her role in leading the $27 billion medical devices segment—the world’s second-largest. At the forefront of innovation, she spearheaded initiatives in telehealth, robotics, and digital surgery, marking her as a trailblazer in advancing integrated, digitized solutions to enhance healthcare outcomes globally.
Notably, McEvoy orchestrated over $20 billion in mergers and acquisitions, strategically expanding the business portfolio and solidifying Johnson & Johnson’s position in the dynamic field of medical devices.
Jon Moeller, P&G’s Chairman of the Board, President, and Chief Executive Officer, expressed enthusiasm about McEvoy’s appointment, emphasizing her transformative leadership and track record of innovation. He highlighted the breadth of her experience in serving consumers and growing markets, positioning McEvoy as a valuable asset to P&G’s mission to enhance the lives of consumers worldwide.
Having held diverse roles at Johnson & Johnson, from Group Chairman of Consumer Medical Devices to Worldwide President of Ethicon Products, McEvoy’s expertise spans various facets of the healthcare industry. Her strategic vision and commitment to growth make her a formidable addition to P&G’s board.
As P&G looks to the future, Ashley McEvoy’s appointment signals a commitment to pushing the boundaries of innovation and consumer well-being. The collaboration between McEvoy and P&G is poised to reshape the landscape of the consumer goods industry, promising exciting developments on the horizon. Stay tuned as this dynamic partnership unfolds, bringing forth a new era of innovation and positive change.